These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35725924)

  • 21. Post-surgical thyroid ablation in intermediate risk-differentiated thyroid cancer patients.
    Rosario PW
    Eur J Endocrinol; 2013 Nov; 169(5):L1. PubMed ID: 24084443
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of postoperative 131I treatment on thyroglobulin measurements in the follow-up of patients with thyroid cancer.
    Baskin HJ
    Thyroid; 1994; 4(3):239-42. PubMed ID: 7833657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Administration of Radioactive Iodine Therapy Within 1 Year After Total Thyroidectomy Does Not Affect Vocal Function.
    Ryu CH; Ryu J; Ryu YM; Lee YJ; Lee EK; Kim SK; Kim TS; Kim TH; Lee CY; Park SY; Chung KW; Jung YS
    J Nucl Med; 2015 Oct; 56(10):1480-6. PubMed ID: 26272814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radioactive iodine: An unappreciated threat to salivary gland function.
    Sunavala-Dossabhoy G
    Oral Dis; 2018 Mar; 24(1-2):198-201. PubMed ID: 29480611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epiphora after radioactive iodine therapy in a low-risk patient.
    Song H; Jeong J; Ju Koh M
    Clin Nucl Med; 2015 Jun; 40(6):536-7. PubMed ID: 25674875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The rationale of patients with early-stage papillary thyroid cancer for accepting or rejecting radioactive iodine remnant ablation.
    Sawka AM; Rilkoff H; Tsang RW; Brierley JD; Rotstein L; Ezzat S; Asa SL; Segal P; Kelly C; Zahedi A; Gafni A; Goldstein DP
    Thyroid; 2013 Feb; 23(2):246-7. PubMed ID: 23009127
    [No Abstract]   [Full Text] [Related]  

  • 27. Radioiodine-remnant ablation in low-risk differentiated thyroid cancer: pros.
    Ain KB
    Endocrine; 2015 Sep; 50(1):61-6. PubMed ID: 26109472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reply to letter: Post-surgical thyroid ablation in intermediate risk-differentiated thyroid cancer patients.
    Pacini F
    Eur J Endocrinol; 2013 Nov; 169(5):L2. PubMed ID: 24084444
    [No Abstract]   [Full Text] [Related]  

  • 29. Unusual case of radioactive iodine-induced Graves' disease with orbitopathy following total thyroidectomy in a patient with papillary thyroid microcarcinoma.
    Zgubieński K; Walczyk A; Kowalska A
    Endokrynol Pol; 2020; 71(3):277-278. PubMed ID: 32293702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salivary gland dysfunction after radioactive iodine (I-131) therapy in patients following total thyroidectomy: emphasis on radioactive iodine therapy dose.
    Lee HN; An JY; Lee KM; Kim EJ; Choi WS; Kim DY
    Clin Imaging; 2015; 39(3):396-400. PubMed ID: 25630229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between excessive urinary iodine excretion and failure of radioactive iodine thyroid ablation in patients with papillary thyroid cancer.
    Sohn SY; Choi JY; Jang HW; Kim HJ; Jin SM; Kim SW; Suh S; Hur KY; Kim JH; Chung JH; Kim SW
    Thyroid; 2013 Jun; 23(6):741-7. PubMed ID: 23205883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Radioactive Iodine Ablation Therapy on Voice Quality.
    Aydoğdu İ; Atar Y; Saltürk Z; Sarı H; Ataç E; Aydoğdu Z; İnan M; Mersinlioğlu G; Uyar Y
    J Voice; 2017 Jan; 31(1):94-96. PubMed ID: 27377232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of radioactive iodine in thyroid carcinoma.
    Goolden AW
    Eur J Cancer Clin Oncol; 1988 Feb; 24(2):339-43. PubMed ID: 3281849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-Activity Radioactive Iodine Therapy for Thyroid Carcinomas Exhibiting Nodal Metastases and Extrathyroidal Extension May Lead to Early Disease Recurrence.
    Chu KP; Baker S; Zenke J; Morad A; Ghosh S; Morrish DW; McEwan AJBS; Williams DC; Severin D; McMullen TPW
    Thyroid; 2018 Jul; 28(7):902-912. PubMed ID: 29742993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The 2009 American Thyroid Association guidelines modestly reduced radioactive iodine use for thyroid cancers less than 1 cm.
    Roman BR; Feingold JH; Patel SG; Shaha AR; Shah JP; Tuttle RM; Epstein AJ
    Thyroid; 2014 Oct; 24(10):1549-50. PubMed ID: 25065817
    [No Abstract]   [Full Text] [Related]  

  • 36. Thyroid cancer patients' involvement in adjuvant radioactive iodine treatment decision-making and decision regret: an exploratory study.
    Sawka AM; Straus S; Gafni A; Meiyappan S; David D; Rodin G; Brierley JD; Tsang RW; Thabane L; Rotstein L; Ezzat S; Goldstein DP
    Support Care Cancer; 2012 Mar; 20(3):641-5. PubMed ID: 22072050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentiated thyroid cancer: lobectomy and radioiodine, a treatment suitable for all cases?
    Allan E; Owens SE; Waller ML
    Nucl Med Commun; 1999 Nov; 20(11):983-9. PubMed ID: 10572907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complications of radioactive iodine treatment of thyroid carcinoma.
    Lee SL
    J Natl Compr Canc Netw; 2010 Nov; 8(11):1277-86; quiz 1287. PubMed ID: 21081784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Is radioiodine treatment necessary after thyroidectomy for "low-risk" differentiated thyroid cancer? : Results of the French prospective randomized multicenter ESTIMBL2 study].
    Bartsch DK; Maurer E
    Chirurgie (Heidelb); 2023 Feb; 94(2):168-169. PubMed ID: 36604319
    [No Abstract]   [Full Text] [Related]  

  • 40. Preablation Diagnostic Whole-Body Scan vs Empiric Radioactive Iodine Ablation in Differentiated Thyroid Cancer: Cost-effectiveness Analysis.
    Arjani S; Quinn PL; Chokshi RJ
    Otolaryngol Head Neck Surg; 2021 Jun; 164(6):1172-1178. PubMed ID: 33076776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.